Yin, Siyu
Liu, Yonghua
Yang, Mingdong
Zhou, Hongning
Yin, Xiaoxiong
Chi, Yong-Tao
Yang, Zhaolan
Chen, Siyu
Qin, Ying
Li, Yu
Li, Zhongjie
Yu, Hongjie
Yang, Weizhong
Funding for this research was provided by:
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2025-RC330-01)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2023-12M-3-011)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-12M-1-044)
National Key Research and Development Program of China (2023YFC2308701)
Beijing Natural Science Foundation (L242053)
Article History
Received: 3 July 2025
Accepted: 9 September 2025
First Online: 10 October 2025
Change Date: 23 November 2025
Change Type: Update
Change Details: The equal contributions sign was removed from the last author.
Declarations
:
: Ethical approval was obtained from the Institutional Review Board of the Chinese Center for Disease Control and Prevention, with written informed consent obtained from all participants or their legal guardians (approval no. 201527). All procedures were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Dr HY has received research funding from Sanofi Pasteur, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Shanghai Roche Pharmaceutical Company, and SINOVAC Biotech Ltd, outside the submitted work. The other authors declare no competing interests.